Acute otitis media treatment market

Acute Otitis Media Treatment Market, by Drug Type (Antibiotics, Nonsteroidal anti-Inflammatory drug, Analgesic, and Anaesthetic), By Formulation (Oral, and Topical), By End User (Hospitals, Retail pharmacies, and Online pharmacies) and Region - Global Trends, and Forecast to 2025

  • Feb 2018
  • CMI1333
  • 178 Pages
  • Excel & Pdf
  • Pharmaceutical

Acute Otitis Media Treatment Market - Insights

Acute otitis media (AOM) is a type of ear infection in which air-filled space behind the eardrum (the middle ear) is infected and causes pain and general symptoms of illness such as fever, irritability and problem in sleeping. AOM is a most common ear infections among children as the Eustachian tube is shorter as compared to adults, which makes it more accessible to bacteria and viruses. Bacteria such as Streptococcus pneumoniae (strep) and Hemophilus influenzae (H. flu) account for around 85% of cases of AOM and viruses account for only 15% of these cases.

Increasing prevalence of AOM disease is expected to drive growth of the acute otitis media treatment market

According to a research published in South African Medical Journal in 2014, global incidence rate of acute otitis media is 10.9% and it was estimated that 80% of children will have at least one episode of acute otitis media (AOM) before the age of 3. Increasing prevalence of acute otitis media is expected to create a conducive environment for growth of acute otitis media treatment market in near future. Furthermore, according to a study published in Formulary Journal in 2014, AOM accounted for healthcare expenditure of around US$ 314 per child per year in the U.S. which is additional US$ 2.88 billion healthcare expenditure. Moreover, stringent guidelines and recommendations in terms of treatment of AOM for children by various non-governmental and governmental bodies is expected to be factor for growth of the market. For instance, in 2013, the American Academy of Pediatrics (AAP) updated the guidelines for treatment of AOM. AAP launched 'The Diagnosis and Management of Acute Otitis Media', in 2013, which provides recommendations to physicians for managing uncomplicated AOM in children. As compared to previous guideline published in 2004, the new guideline has added more criteria for diagnosing AOM. This update in guideline is expected to help in better diagnosis and higher treatment rate, which may boost growth of the global acute otitis media treatment market.

The global acute otitis media treatment market was valued at US$ 1,943.9 million in 2016 and is expected to witness a CAGR of 5.1% over the forecast period (2017–2025).

Figure 1. Global Acute Otitis Media Treatment Market Share (%), By Region, 2017–2025

Source: Coherent Market Insights Analysis (2017)

Launch of novel drugs is expected to support growth of acute otitis media treatment market in the near future

Launching of new products for acute otitis media treatment by key players are factors expected to create a conducive environment for market growth in the near future. For instance, in 2016, Laboratorios SALVAT S.A. and Arbor Pharmaceuticals, LLC launched its OTOVEL (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %). This solution is indicated for the treatment of acute otitis media with tympanostomy tubes (AOMT) in pediatric patients. Moreover, in 2016, Otonomy, Inc. launched its OTIPRIO (ciprofloxacin otic suspension), indicated for the treatment of pediatric patients with bilateral acute otitis media in the U.S.

Presence of generic drugs, at much lower price compared to branded drugs, in market for the treatment of acute otitis media is the major factor which is expected to hamper the growth in near future. For instance, in 2015, Aurobindo Pharma Ltd. received US FDA approval to launch its generic antibiotic Cefixime in the U.S. market. Cefixime is a third generation cephalosporin indicated for the treatment of acute otitis media.

Furthermore, key players manufacturing drugs for treatment of acute otitis media are focusing on increasing their online presence, by launching websites, in order to expand their customer base. For instance, in 2013, Alcon launched its DROPS101 Web Tools — a mobile website that provides educational resource about commonly prescribed eye and ear treatments. DROPS101 Web Tools offers product information related to the treatment of acute otitis media.

Key players operating in the acute otitis media treatment market include Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG, Novartis AG, Pediapharm Inc., Sanofi S.A., and Bristol Myers Squibb Company.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Formulation
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Technological Trends
    • Unmet Needs
    • Regulatory Scenario
    • Recent Product Approvals/Launch
    • Technological Advancement
    • PEST Analysis
    • Porter’s Five Forces Analysis
  4. Global Acute Otitis Media Treatment Market, By Drug Type, 2016–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Antibiotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Nonsteroidal anti-Inflammatory drug
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Analgesic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Anaesthetic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
  5. Global Acute Otitis Media Treatment Market, By Formulation, 2017–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
  6. Global Acute Otitis Media Treatment Market, By Distribution Channel, 2016–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Hospital
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Retail pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Online pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
  7. Global Acute Otitis Media Treatment Market, By Region, 2016–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2016–2025
    • North America
      • Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • Central Africa
        • South Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Eli Lilly and Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • GlaxoSmithKline plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bayer AG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pediapharm Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sanofi S.A.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bristol Myers Squibb Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 42 figures on “Acute Otitis Media Treatment Market - Global forecast to 2025”.

N/A
- Frequently Asked Questions -

What are the growth estimates for acute otitis media treatment markettill 2025?

The global acute otitis media treatment market is estimated to surpass US$ 3,200.5 Million by 2025.

Which are the prominent acute otitis media treatment market players across the globe?

Major players operating in the global acute otitis media treatment market include Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG, Novartis AG, Pediapharm Inc., Sanofi S.A., and Bristol Myers Squibb Company

What are the key factors hampering growth of the acute otitis media treatment market?

Presence of generic drugs, at much lower price compared to branded drugs, in market for the treatment of acute otitis media is one of the major factors that is expected to hamper growth of the market over the forecast period.

What are the key factors driving growth of the acute otitis media treatment market?

Increasing prevalence of AOM disease is one of the major factors that is expected to propel growth of the market over the forecast period.

What is the Compound Annual Growth Rate (CAGR) of the acute otitis media treatment market for next 8 years?

The global acute otitis media treatment market is estimated to exhibit a CAGR of 5.1% over the forecast period

Which region is dominating theacute otitis media treatment market growth?

Among regions, North Americais expected to hold dominant position in the global acute otitis media treatment market over the forecast period.
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.